Prenatal diagnosis and genetic analysis of type I and type II thanatophoric dysplasia

Prenatal Diagnosis

Volumn 21, Issue 2, 2001, Pages 89-95

  Chen, Chih Ping ^a,b   Chern, Schu Rern ^b   Shih, Jin Chung ^c   Wang, Wayseen ^b   Yeh, Li Fan ^a   Chang, Tung Yao ^a   Tzen, Chin Yuan ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

FGFR3 gene; Gene mutation; Prenatal diagnosis; Thanatophoric dysplasia; Three dimensional ultrasound

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 3; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ECHOGRAPHY; FETUS; GENETIC ANALYSIS; HUMAN; MISSENSE MUTATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; THANATOPHORIC DWARFISM; THREE DIMENSIONAL IMAGING;

ADULT; DNA RESTRICTION ENZYMES; FEMALE; GESTATIONAL AGE; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECEPTORS, FIBROBLAST GROWTH FACTOR; THANATOPHORIC DYSPLASIA; ULTRASONOGRAPHY, PRENATAL;

EID: 0035099946     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0223(200102)21:2<89::AID-PD21>3.0.CO;2-9     Document Type: Article

References (36)

1. Achondroplasia is defined by recurrent G380R mutations of FGFR3
2. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 gene causes hypochondroplasia
3. Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes
4. Mutational analysis of FGFR3 in thanatophoric dysplasia type I
5. Common mutations in the fibroblast growth factor receptor 3 (FGFR3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism
6. Platyspondylic lethal skeletal dysplasia, San Diego type, is caused by FGFR3 mutations
7. An unusual radiological finding in thanatophoric dysplasia type I with common mutation of the fibroblast growth factor receptor-3 (FGFR3) gene (Arg248Cys)
8. Achondroplasia, hypochondroplasia and thanatophoric dysplasia: Clinically related skeletal dysplasias that are also related at the molecular level
9. Asn540Thr substitution in the fibroblast growth factor receptor 3 tyrosine kinase domain causing hypochondroplasia. Hum Mutat Online #37
10. A novel missense mutation Ile538Val in fibroblast growth factor receptor 3 in hypochondroplasia
11. Mutations of the fibroblast growth factor receptor-3 gene in one familial and six sporadic cases of achondroplasia in Japanese patients
12. Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3
13. Lys650Met substitution in the tyrosine kinase domain of the fibroblast growth factor receptor gene causes thanatophoric dysplasia type I. Hum Mutat Online #199
14. Thanatophoric dysplasia and cloverleaf skull
15. Le nanisme thanatophore [Thanatophoric dwarfism]
16. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans
17. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome
18. Radiological and histological variants of thanatophoric dysplasia are associated with common mutations in FGFR-3
19. Thanatophoric dysplasia of the straight-bone type (type 2)
20. The birth prevalence rates for the skeletal dysplasias
21. Clinical spectrum of fibroblast growth factor receptor mutations
22. Genomic organization of the human fibroblast growth factor receptor 3 (FGFR3) gene and comparative sequence analysis with the mouse Fgfr3 gene
23. A common FGFR3 gene mutation in hypochondroplasia
24. Comparison of clinical radiological and molecular findings in hypochondroplasia
25. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia
26. Stop codon FGFR3 mutations in thanatophoric dwarfism type I
27. Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1)
28. Clinical and genetic heterogeneity of hypochondroplasia
29. Prenatal diagnosis of thanatophoric dysplasia by mutational analysis of the fibroblast growth factor receptor 3 gene and a proposed correction of previously published PCR results
30. Antenatal sonographic diagnosis of thanatophoric dysplasia: A report of three cases and a review of the literature with special emphasis on the differential diagnosis
31. The lethal osteochondrodysplasias
32. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3
33. A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene
34. Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia
35. A recurrent mutation, ala391glu, in the transmembrane region of FGFR3 causes Crouzon syndrome and acanthosis nigricans
36. The skeletal system